Interpace Diagnostics Group, Inc. (75) | Human Resources (14)
Browse by Subcategory
Recent Contracts
-
Employment agreement entered into May 10, 2021, effective February 1, 2021, between Thomas Freeburg and the Company
(Filed With SEC on May 11, 2021)
-
Severance Agreement and General Release, dated January 31, 2021, by and between the Company and Fred Knechtel
(Filed With SEC on February 4, 2021)
-
Separation and Consulting Agreement and General Release, dated November 23, 2020, between Jack E. Stover and Interpace Biosciences, Inc
(Filed With SEC on November 25, 2020)
-
Amendment to the Interpace Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on June 26, 2020)
-
Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc
(Filed With SEC on July 19, 2019)
-
Employment Separation Agreement between Interpace Diagnostics, LLC and Gregory Richard, effective as of March 25, 2015
(Filed With SEC on March 21, 2019)
-
Employment Agreement, dated November 23, 2020, between Thomas W. Burnell and Interpace Biosciences, Inc
(Filed With SEC on November 25, 2020)
-
Form of Interpace Biosciences, Inc. 2019 Equity Incentive Plan Restricted Stock Unit And Restricted Stock Unit Agreement
(Filed With SEC on June 26, 2020)
-
Severance and Consulting Agreement and General Release, dated January 29, 2020, by and between Interpace Biosciences, Inc. and James Early
(Filed With SEC on January 31, 2020)
-
Employment Agreement, dated as of January 29, 2020, by and between Interpace Biosciences, Inc. and Fred Knechtel
(Filed With SEC on January 31, 2020)
-
First Amendment to Amended and Restated Employment Agreement, dated January 29, 2020, by and between Interpace Biosciences, Inc. and Jack E. Stover
(Filed With SEC on January 31, 2020)
-
Interpace Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on November 14, 2019)
-
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on November 14, 2019)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on November 14, 2019)